LDL size: does it matter?

The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.

[1]  R. Krauss,et al.  Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter. , 2004, Metabolism: clinical and experimental.

[2]  R. Krauss,et al.  Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Lipton,et al.  Unique lipoprotein phenotype and genotype associated with exceptional longevity. , 2003, JAMA.

[4]  D. Capuzzi,et al.  Effects of extended-release niacin on lipoprotein subclass distribution. , 2003, The American journal of cardiology.

[5]  M. Taskinen,et al.  Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS) , 2003, Circulation.

[6]  B. Lamarche,et al.  Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia. , 2003, Atherosclerosis.

[7]  C. Barbagallo,et al.  Low‐density‐lipoprotein peak particle size in a Mediterranean population , 2003, European journal of clinical investigation.

[8]  R. Krauss,et al.  Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 , 2002, Journal of Lipid Research.

[9]  G. Dagenais,et al.  Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease , 2001, Circulation.

[10]  F. Sacks,et al.  Low-density lipoprotein size, pravastatin treatment, and coronary events. , 2001, JAMA.

[11]  J. Segrest,et al.  Structure of apolipoprotein B-100 in low density lipoproteins. , 2001, Journal of lipid research.

[12]  G. Dagenais,et al.  A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. , 2001, The Canadian journal of cardiology.

[13]  R. Krauss,et al.  Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. , 2001, The American journal of medicine.

[14]  A. Golay,et al.  Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. , 2000, The American journal of clinical nutrition.

[15]  M. Laakso,et al.  Men and Women , 1901 .

[16]  J. Hokanson,et al.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. , 1999, Circulation.

[17]  R. Deckelbaum,et al.  Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. , 1998, Journal of lipid research.

[18]  R. Krauss,et al.  LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[20]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[21]  G. Bondjers,et al.  Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. , 1996, Atherosclerosis.

[22]  M. Laakso,et al.  Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. , 1995, Circulation.

[23]  G. Franceschini,et al.  Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction. , 1995, Atherosclerosis.

[24]  R. Krauss,et al.  Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. , 1995, Journal of lipid research.

[25]  A. van Tol,et al.  Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. , 1994, Atherosclerosis.

[26]  J. Ordovás,et al.  Familial hypoalphalipoproteinemia in premature coronary artery disease. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  J. Coresh,et al.  Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. , 1993, Journal of lipid research.

[28]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[29]  C. Packard,et al.  Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  M. Austin,et al.  Genetic epidemiology of low-density lipoprotein subclass phenotypes. , 1992, Annals of medicine.

[31]  E. Blijlevens,et al.  LDL particle size distribution. Results from the Framingham Offspring Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[33]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[35]  R. Krauss,et al.  Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. , 1990, Arteriosclerosis.

[36]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[37]  G. Camejo,et al.  Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. , 1985, Atherosclerosis.

[38]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[39]  R. Krauss,et al.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Camejo,et al.  The interaction of low density lipoproteins with arterial proteoglycans. An additional risk factor? , 1980, Atherosclerosis.

[41]  T. Lassel,et al.  Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  D. Swinkels,et al.  Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls. , 1993, The Journal of clinical endocrinology and metabolism.

[43]  Ronald M. Krauss,et al.  A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK , 1990 .

[44]  W L Haskell,et al.  Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. , 1989, The Journal of clinical endocrinology and metabolism.